Title: Sae Won Kim: Innovator in Cancer Immunotherapy
Introduction
Sae Won Kim is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of cancer immunotherapy through her innovative research and development. Although she currently holds no granted patents, her work is paving the way for future advancements in medical treatments.
Latest Patent Applications
Sae Won Kim's latest patent applications include two notable inventions. The first is titled "Genetically Modified NK Cell Line Transduced with Gene Encoding Novel Chimeric Antigen Receptor and Use Thereof." This invention provides a genetically modified NK cell line prepared by transducing a host NK cell line with a gene construction encoding a cancer antigen-specific chimeric antigen receptor (CAR). This innovation aims to enhance immunotherapy for acute myeloid leukemia.
The second application is "Vector Simultaneously Expressing Dodecameric TRAIL and HSV-TK Suicide Genes, and Anticancer Stem Cell Therapeutic Agent Using Same." This invention relates to a DNA cassette comprising a nucleotide sequence encoding dodecameric TRAIL and a suicide gene nucleotide sequence. It also includes a recombinant expression vector and a method for treating cancer, demonstrating more effective anticancer effects than known therapies.
Conclusion
Sae Won Kim is an innovative force in the field of cancer treatment, focusing on advanced immunotherapy techniques. Her latest patent applications reflect her commitment to improving patient outcomes in oncology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.